US Stock MarketDetailed Quotes

VRCA Verrica Pharmaceuticals

Watchlist
  • 0.777
  • +0.016+2.12%
Trading Dec 16 11:24 ET
70.37MMarket Cap-0.42P/E (TTM)

Verrica Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Verrica Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 2.109M--
--2024/Q4-- / 710.330K--
--2024/Q3-1.781M / 5.262M--
Aug 14, 20242024/Q25.177M / 4.550M--
May 13, 20242024/Q13.826M / 2.651M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 2.109M--
--2024/Q4-- / 710.330K--
--2024/Q3-1.781M / 5.262M--
Aug 14, 20242024/Q25.177M / 4.550M--
May 13, 20242024/Q13.826M / 2.651M--

Unlock Free Earnings Estimates

Verrica Pharmaceuticals Earnings Reports

  • Verrica Pharmaceuticals | 10-Q: Q3 2024 Earnings Report

    Nov 5 11:58 ET

  • Verrica Pharmaceuticals | 8-K: Verrica Pharmaceuticals Reports Third Quarter 2024 Financial Results and Announces Leadership Transition

    Nov 4 16:20 ET

  • Verrica Pharmaceuticals | 10-Q: Q2 2024 Earnings Report

    Aug 14 08:09 ET

  • Verrica Pharmaceuticals | 8-K: Verrica Pharmaceuticals Reports Second Quarter 2024 Financial Results

    Aug 14 07:59 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 30, 2024

    Hold

    • Buy

      20.00%

    • Hold

      80.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Price
    % Chg

    No Data